Overview The global TCR-based antibody market is projected to reach USD 14,821.1 million by 2033, increasing from USD 3,600.4 million in 2023, at a CAGR of 15.2% during 2024–2033. The market’s expansion is driven by the growing ability of TCR-based antibodies to target intracellular antigens presented by MHC molecules. Unlike conventional antibodies limited to surface […] The post TCR-Based Antibody Market Eyes USD 14.8 Billion by 2033, Driven by R&D Growth appeared first on Market.us M...| Market.us Media
Pancreatic Amylase Reagent Market Size is expected to reach USD 487.8 Mn by 2033, growing at a CAGR of 5.2% during forecast (2024-2033).| Market.us Media